LindaClaudetteStorkMD

Pediatric Hematology & Oncology • Portland, OR

Associate Professor of Pediatrics, Oregon Health & Sci University

Join to view full profile

Dr. Stork is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Stork's full profile

Already have an account?

Office
3181 Sw Sam Jackson Park Rd

Portland, OR 97239
Phone+1 503-494-0829
Is this information wrong?

Education & Training

University of ColoradoFellowship, Pediatric Hematology/Oncology, 1982 - 1986
University of ColoradoResidency, Pediatrics, 1981 - 1982
New York Presbyterian Hospital (Columbia Campus)Residency, Pediatrics, 1979 - 1981
Columbia University Vagelos College of Physicians and SurgeonsClass of 1979

Certifications & Licensure

WA State Medical License 2023 - 2026
OR State Medical License 2002 - 2025
CO State Medical License 1982 - 2003
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Portland Monthly Magazine Castle Connolly, 2011

Clinical Trials

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 1996 May 01
Completed
Phase 3
Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors Start of enrollment: 2003 Oct 01
Completed
Phase 1
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2005 Apr 11
Completed
Phase 3
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
Active, not recruiting
Phase 2
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2014 Mar 28
Completed
Phase 1, Phase 2
Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies Start of enrollment: 2014 May 16
Completed
Phase 1, Phase 2
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults Start of enrollment: 2020 Oct 02
Recruiting
Phase 1
Roles: Contact
Fimepinostat in Treating Brain Tumors in Children and Young Adults Start of enrollment: 2019 Aug 07
Active, not recruiting
Early Phase 1
Roles: Contact
BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas Start of enrollment: 2019 Apr 03
Recruiting
Phase 1
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

6 citations
Functional impact and targetability of,, andmutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation.
Florence Choo, Igor Odintsov, Kevin Nusser, Katelyn S Nicholson, Lara Davis, Christopher L Corless, Linda Stork, Romel Somwar, Marc Ladanyi, Jessica L Davis, Monika A ...> ;Cold Spring Harbor Molecular Case Studies. 2022 Jan 1
17 citations
Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331
Leonard A. Mattano, Meenakshi Devidas, Kelly W. Maloney, Cindy Wang, Alison M. Friedmann, Patrick J. Buckley, Michael J. Borowitz, Andrew J. Carroll, Julie M. Gastier-...> ;Journal of Clinical Oncology. 2021 Mar 19
5 citations
Parental decision making regarding consent to randomization on Children's Oncology Group AALL0932.
Kellee Parker, Erika Cottrell, Linda C. Stork, Susan Lindemulder> ;Pediatric Blood & Cancer. 2021 Jan 26
90 citations
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0331
Kelly W. Maloney, Meenakshi Devidas, Cindy Wang, Leonard A. Mattano, Alison M. Friedmann, Patrick J. Buckley, Michael J. Borowitz, Andrew J. Carroll, Julie M. Gastier-...> ;Journal of Clinical Oncology. 2020 Feb 20
8 citations
Optimizing Time to Antibiotic Administration in Children with Possible Febrile Neutropenia through Quality Improvement Methodologies.
Beech Burns, Melinda Hartenstein, Amber Lin, Denise Langley, Erin Burns, James A. Heilman, Mary Tanski, Linda C. Stork, O. John Ma> ;Pediatric Quality & Safety. 2019 Nov 21
13 citations
Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children’s Oncology Group
Yousif Matloub, Karen R. Rabin, Lingyun Ji, Meenakshi Devidas, Johann Hitzler, Xinxin Xu, Bruce Bostrom, Linda C. Stork, Naomi J. Winick, Julie M. Gastier-Foster, Nyla...> ;Blood Advances. 2019 Jun 11
15 citations
Delirium in the pediatric hematology, oncology, and bone marrow transplant population.
Katrina Winsnes, Paul Sochacki, Carl Eriksson, Evan Shereck, Michael Recht, Kyle P. Johnson, Rebecca Loret De Mola, Linda C. Stork> ;Pediatric Blood & Cancer. 2019 Jun 1
13 citations
Safety and efficacy of high-dose methotrexate for osteosarcoma in adolescents compared with young adults
Brittany Wippel, Kenneth R. Gundle, Theresa Dang, Jillian Paxton, Joseph S. Bubalo, Linda C. Stork, Rongwei Fu, Christopher W. Ryan, Lara E. Davis> ;Cancer Medicine. 2019 Jan 1
58 citations
Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial.
Lia Gore, Pamela Kearns, Maria Lucia de Martino Lee, Carmino Antonio De Souza, Yves Bertrand, Nobuko Hijiya, Linda C. Stork, Nack Gyun Chung, Rocio Cardenas Cardos, Ta...> ;Journal of Clinical Oncology. 2018 Mar 2
15 citations
Early career mentoring through the American Society of Pediatric Hematology/Oncology: Lessons learned from a pilot program
Sherif M. Badawy, Vandy Black, Emily Riehm Meier, Kasiani C. Myers, Kerice Pinkney, Caroline Hastings, Joanne M. Hilden, Patrick A. Zweidler-McKay, Linda C. Stork, The...> ;Pediatric Blood & Cancer. 2017 Mar 1
4 citations
Dexamethasone Chemotherapy Does Not Disrupt Orexin Signaling.
David E. Kram, Stephanie M. Krasnow, Peter R. Levasseur, Xinxia Zhu, Linda C. Stork, Daniel L. Marks> ;Plos One. 2016 Dec 20
5 citations
Navigating your career path in pediatric hematology/oncology: On and off the beaten track
Patrick A. Zweidler-McKay, Mary Jane Staba Hogan, Rima Jubran, Vandy Black, Jacqueline Casillas, James Harper, Suman Malempati, Judith F. Margolin, Judy Felgenhauer, K...> ;Pediatric Blood & Cancer. 2016 Oct 1
17 citations
Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia—Comparison among Different Treatment Strategies
Yousif Matloub, Linda C. Stork, Barbara L. Asselin, Stephen P. Hunger, Michael J. Borowitz, Tamekia L. Jones, Bruce Bostrom, Julie M. Gastier-Foster, Nyla A. Heerema, ...> ;Pediatric Blood & Cancer. 2016 Feb 1
1 citations
Reply to: Obesity is an important health problem in survivors of pediatric acute lymphoblastic leukemia.
Susan J Lindemulder, Linda C Stork, Xiaomin Lu, Stephen Hunger, Joseph P Neglia, Nina S Kadan-Lottick> ;Pediatric Blood & Cancer. 2015 Nov 1
Obesity is an important health problem in survivors of pediatric acute lymphoblastic leukemia.
Fang F Zhang, Michael J Kelly, Aviva Must, Edward Saltzman, Susan K Parsons> ;Pediatric Blood & Cancer. 2015 Nov 1
14 citations
Preventive antibiotics in pediatric patients with acute myeloid leukemia (AML).
Dawn Nolt, Susan Lindemulder, Jeffrey Meyrowitz, Bill H. Chang, Suman Malempati, Gregory Thomas, Linda C. Stork> ;Pediatric Blood & Cancer. 2015 Jul 1
26 citations
Survivors of standard risk acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: a report from the Children'...
Susan Lindemulder, Linda C. Stork, Bruce Bostrom, Xiaomin Lu, Meenakshi Devidas, Stephen P. Hunger, Joseph P. Neglia, Nina S. Kadan-Lottick> ;Pediatric Blood & Cancer. 2015 Jun 1
1 citations
Associations between genetic variants in folate and drug metabolizing pathways and relapse risk in pediatric acute lymphoid leukemia on CCG-1952
Marijana Vujkovic, Aaron Kershenbaum, Lisa Wray, Thomas McWilliams, Shannon Cannon, Meenakshi Devidas, Linda C. Stork, Richard Aplenc> ;Leukemia Research Reports. 2015 Jan 1
27 citations
Family life events in the first year of acute lymphoblastic leukemia therapy: a children's oncology group report.
Samantha Lau, Xiaomin Lu, Lyn Balsamo, Meenakshi Devidas, Naomi J. Winick, Stephen P. Hunger, William L. Carroll, Linda C. Stork, Kelly W. Maloney, Nina S. Kadan-Lottick> ;Pediatric Blood & Cancer. 2014 Dec 1
10 citations
TPMT and MTHFR genotype is not associated with altered risk of thioguanine‐related sinusoidal obstruction syndrome in pediatric acute lymphoblastic leukemia: A report ...
Lisa Wray, Marijana Vujkovic, Thomas McWilliams, Shannon Cannon, Meenakshi Devidas, Linda C. Stork, Richard Aplenc> ;Pediatric Blood & Cancer. 2014 Nov 1
80 citations
Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease
Stephen J. Simko, Huy D. Tran, Jeremy Jones, Mrinalini Bilgi, Lynda K. Beaupin, Don W. Coulter, Timothy P. Garrington, Timothy L. McCavit, Colin Moore, Francisco River...> ;Pediatric Blood & Cancer. 2014 Mar 1
31 citations
Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph+ALL: a Children’s Oncology Group (COG) study
Bill H. Chang, Stephanie G. Willis, Linda C. Stork, Stephen P. Hunger, William L. Carroll, Bruce M. Camitta, Naomi J. Winick, Brian J. Druker, Kirk R. Schultz> ;British Journal of Haematology. 2012 May 1
43 citations
Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia
Maynika V. Rastogi, Linda C. Stork, Brian J. Druker, Carolyn Blasdel, Thuan Nguyen, Bruce A. Boston> ;Pediatric Blood & Cancer. 2012 Feb 29
101 citations
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Yousif Matloub, Bruce Bostrom, Stephen P. Hunger, Linda C. Stork, Anne L. Angiolillo, Harland N. Sather, Mei La, Julie M. Gastier-Foster, Nyla A. Heerema, Scott L. Sai...> ;Blood. 2011 Jul 14
28 citations
Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia
Gabriele Escherich, Sue Richards, Linda C. Stork, Ajay Vora> ;Leukemia. 2011 Mar 4
Join now to see all

Grant Support

CCG 2961: Children W/ Untreated AML Immune Modulation Phase W/ IL 2National Center For Research Resources1999–2000
Pilot Trial With 6 ThioguanineNational Center For Research Resources1996–1997

Hospital Affiliations

OHSU HospitalPortland, Oregon

LindaClaudetteStorkMD

Dr. Stork is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Grant Support

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.